Q&A: How the COVID-19 Pandemic Changed the Landscape of Pharmacy
Drug Topics
MARCH 19, 2025
Jeffrey Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, reflects on the COVID-19 pandemic 5 years later.
Drug Topics
MARCH 19, 2025
Jeffrey Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, reflects on the COVID-19 pandemic 5 years later.
Pharma Marketing Network
MARCH 19, 2025
Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 19, 2025
Researchers explored how social media advertising of lifestyle drugs contributes to the normalization of use for semaglutide, testosterone, and sildenafil.
PharmaVoice
MARCH 19, 2025
Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles could stymie dealmaking.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 19, 2025
In an Axios analysis of US Senate lobbying disclosures from the past year, researchers explored the ongoing trends of how certain industries distribute influence among legislators.
Pharma Marketing Network
MARCH 19, 2025
Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
MARCH 19, 2025
Explore how Tufts Center for the Study of Drug Development (CSDD) has spearheaded the growth of digital clinical trials through an initial leap of faith. Learn more about todays fast-growing movement in the field.
Drug Topics
MARCH 19, 2025
A recent study found that continuous glucose monitors could help improve patient comfort, reduce resource use, and improve outcomes.
pharmaphorum
MARCH 19, 2025
The death of a patient treated with Sarepta's Duchenne muscular dystrophy gene therapy Elevidys has hit its share price
Drug Topics
MARCH 19, 2025
Jade Ranger, PharmD, discusses her experiences during the COVID-19 pandemic as one of the first pharmacies to receive the COVID-19 vaccines.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
MARCH 19, 2025
Top officials first aimed to slash everything within 48 hours. It has since backtracked and says the HIV Prevention program may be reorganized into HRSA, or less drastically cut.
Pharmacy Times
MARCH 19, 2025
As demand for GLP-1 therapies grows, patients face rising costs and restrictive insurance policies.
Fierce Healthcare
MARCH 19, 2025
Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs.
Pharmacy Times
MARCH 19, 2025
Results highlight promising advancements in novel treatments for patients with HIV-1, including a combination regimen with broadly neutralizing antibodies and long-term data on bictegravir, emtricitabine, and tenofovir alafenamide (Biktarvy).
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MARCH 19, 2025
Urgent care provider CityMD inked a multi-year partnership with Notable to integrate artificial intelligence and automation technology into its nearly 200 clinics.
Pharmacy Times
MARCH 19, 2025
Exidavnemab is a novel monoclonal antibody with disease-modifying potential.
pharmaphorum
MARCH 19, 2025
Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month
Fierce Healthcare
MARCH 19, 2025
Renovations, recruitment and technology adoption are timed to stand up the in-house Mass General Brigham Cancer before a long-standing partnership with the Dana-Farber Cancer Institute concludes in fall 2028.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MARCH 19, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of my colleagues are traveling to New York today to get ready for our Breakthrough East Summit happening tomorrow.
Pharmaceutical Technology
MARCH 19, 2025
Purdue Pharmas new bankruptcy plan outlines the payment structure of the largest opioid settlement to date.
Fierce Healthcare
MARCH 19, 2025
Cigna has officially sealed the deal on the $3.3 billion sale of its Medicare business to Health Care Service Corporation. | Cigna has officially sealed the deal on the $3.3 billion sale of its Medicare business to Health Care Service Corporation.
pharmaphorum
MARCH 19, 2025
Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto
Pharmacy Times
MARCH 19, 2025
The combination was approved for treatment of patients with gastroesophageal junction (GEJ) adenocarcinoma.
Fierce Healthcare
MARCH 19, 2025
Fierce Healthcare unveiled its seventh annual Fierce 15 earlier this month, introducing th | Executive Editor Heather Landi and Senior Writer Paige Minemyer sit down to chat about the evolution of the Fierce 15 project and honorees.
Pharmacy Times
MARCH 19, 2025
Prioritizing preventive measures for high-risk individuals would effectively address half of RSV hospitalizations.
pharmaphorum
MARCH 19, 2025
Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche
Pharmacy Times
MARCH 19, 2025
Approximately 74% of patients with chronic rhinosinusitis with nasal polyps receiving depemokimab across 2 trials did not need additional intervention.
Pharmaceutical Technology
MARCH 19, 2025
While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing interest.
Pharmacy Times
MARCH 19, 2025
Ononogbu discusses research, health equity, and sickle cell advancements.
Pharmaceutical Technology
MARCH 19, 2025
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals Cirara, aimed at treating LHI.
Pharmacy Times
MARCH 19, 2025
Patients with a disorder from this family of neurodevelopmental conditions face a lack of approved treatment options, making radiprodil poised to transform the treatment paradigm.
Pharmaceutical Commerce
MARCH 19, 2025
The conferences first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and Medicare Prescription Payment Plan via the PAN Foundations latest research.
Pharmaceutical Technology
MARCH 19, 2025
Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system diseases.
Let's personalize your content